Benefits
Zero-Calorie Sugar Replacement
Steviol glycosides are 200-400× sweeter than sucrose with no caloric contribution. Useful for caloric reduction in beverages, foods, and as tabletop sweetener. No glycemic impact — safe for diabetics.
Glycemic Control / Diabetes-Friendly
Multiple trials show stevia does not raise blood glucose or insulin in diabetic and non-diabetic subjects. Replacing sucrose with stevia in beverages reduces postprandial glucose spikes. Safe option for diabetes management.
Modest Blood Pressure Effects
Hsieh 2003 trial in hypertensive patients showed stevioside (1,500 mg/day for 2 years) modestly reduced blood pressure. Effect smaller than antihypertensive drugs but documented. Mechanism may involve calcium channel modulation.
Dental Health Benefits
Stevia is non-cariogenic — does not promote tooth decay. Some evidence stevia inhibits oral bacterial growth (Streptococcus mutans). Used in toothpastes and chewing gums for dental health.
Caloric Reduction Public Health Impact
Replacing sugar-sweetened beverages with stevia-sweetened versions reduces caloric intake — relevant for obesity prevention. Not a weight-loss intervention per se but useful tool.
Mechanism of action
Sweet Taste Receptor (T1R2/T1R3) Activation
Steviol glycosides bind to sweet taste receptors (heterodimer of T1R2 and T1R3) on the tongue, producing sweet taste perception. Higher binding affinity than sucrose accounts for 200-400× sweetness intensity. Not metabolized for energy.
Gut Microbiome Metabolism
Steviol glycosides are NOT absorbed intact in upper GI; pass to colon where gut bacteria hydrolyze glucose units to release STEVIOL aglycone, which is absorbed and excreted in urine as steviol glucuronide. This explains the 'no caloric impact' claim and why effects in cell culture differ from oral exposure.
Calcium Channel Modulation (Hypotensive Mechanism)
Stevioside modulates calcium channels in vascular smooth muscle — basis for modest hypotensive effects.
Bitter / Aftertaste Profile
Some users perceive licorice-like aftertaste or bitterness — depends on glycoside profile. Reb A and Reb M have cleaner taste than stevioside; modern products use higher Reb A content for improved palatability.
Clinical trials
RCT of stevioside (1,500 mg/day) vs placebo in 174 mild hypertensive patients for 2 years.
174 hypertensive patients.
Significant reduction in systolic and diastolic BP vs placebo at 12 and 24 months. Small magnitude (~10 mmHg systolic) but sustained. Generated interest in stevia for cardiovascular applications.
Multiple RCTs of stevia replacement of sucrose on postprandial glucose and insulin.
Type 2 diabetic and non-diabetic populations.
Stevia does not raise glucose or insulin. Replacing sucrose with stevia in beverages reduces postprandial spikes. Established stevia as diabetes-friendly sweetener.
About this ingredient
STEVIA (STEVIA REBAUDIANA) is a SOUTH AMERICAN PLANT (native to Paraguay/Brazil) whose leaves contain SWEET COMPOUNDS called STEVIOL GLYCOSIDES. Used by GUARANI PEOPLE for centuries (called 'ka'a he'ê' meaning 'sweet herb').
FORMS: (1) WHOLE-LEAF STEVIA (dried leaves) — NOT FDA-approved as sweetener for food; sold as supplement; (2) CRUDE STEVIA EXTRACT (low-purity) — NOT FDA-approved; (3) PURIFIED STEVIOL GLYCOSIDES (≥95% steviol glycosides — Reb A or stevioside) — GRAS-recognized by FDA.
KEY ACTIVE COMPOUNDS: STEVIOSIDE (most abundant traditionally; ~5-10% of leaf dry weight) and REBAUDIOSIDE A (Reb A) — both ~200-400× sweeter than sucrose. Modern products favor REB A and REB M (less aftertaste than stevioside). PHARMACOLOGY: steviol glycosides NOT absorbed intact; gut bacteria hydrolyze glucose units to release STEVIOL aglycone, absorbed and excreted as steviol glucuronide in urine.
EVIDENCE-BASED USES: (1) ZERO-CALORIE SWEETENER — replaces sucrose without glycemic impact; (2) DIABETES-FRIENDLY sweetener; (3) Modest BP reduction (Hsieh 2003); (4) Dental health (non-cariogenic); (5) Caloric reduction strategies.
CRITICAL CAUTIONS: (1) FDA REGULATORY STATUS — only PURIFIED STEVIOL GLYCOSIDES (≥95% Reb A or stevioside) are FDA GRAS; whole-leaf stevia and crude extracts are NOT approved as food sweeteners (sold as supplements only); (2) ASTERACEAE ALLERGY — stevia is in Asteraceae family (ragweed, daisy, chrysanthemum, marigold, chamomile); cross-reactive allergy possible; (3) HYPOGLYCEMIA — modest hypoglycemic effects reported; relevant for those on diabetes medications; monitor; (4) HYPOTENSION — modest hypotensive effects (especially at higher doses); relevant for those on antihypertensives; (5) ADI — Acceptable Daily Intake established by JECFA and EFSA: 4 mg/kg body weight per day of STEVIOL EQUIVALENTS (~12 mg/kg/day of steviol glycosides — accounting for the molecular weight difference); for 70kg adult ~840 mg steviol glycosides daily — easily within typical sweetener use; (6) PREGNANCY/LACTATION — purified steviol glycosides considered safe at moderate intake; whole-leaf stevia limited safety data; pregnant women in some cultures use whole-leaf stevia traditionally for blood pressure; modern recommendation is moderate intake of purified forms; (7) AFTERTASTE — stevioside has more licorice-like aftertaste than Reb A; Reb M (newer) has even cleaner taste; product choice affects palatability; (8) INDUSTRIAL FORMS — many commercial stevia products are 'Reb A 97%' (Truvia® base), which is favored over crude extracts; (9) BLENDS — many tabletop products blend stevia with erythritol or other bulking agents — read labels for total composition; (10) INFERTILITY HISTORICAL CONCERN — older animal studies suggested anti-fertility effects from VERY HIGH doses of crude extracts; not replicated with purified glycosides at human-relevant doses; minor concern at typical use; (11) BAKING/COOKING — stevia is heat-stable; works for baking (with bulking agent for volume) but doesn't provide browning, structure, or moisture like sugar; (12) WHOLE-LEAF VS PURIFIED — whole-leaf stevia (sold as supplement) provides additional plant compounds but variable composition; for predictable sweetening, purified forms preferred.